NORMAL SITUATION

MEDISCH LABORATORIUM

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

385,2 k €

+268.5% YoY

Gross margin

1,9 M €

+50.0% YoY

Equity

778,2 k €

-34.8% YoY

Workforce

18,6 ETP

-2.1% YoY

Company — Normal situation.

Strike-off: 19 septembre 2026

What does MEDISCH LABORATORIUM do?

MEDISCH LABORATORIUM is a Private limited company incorporated in 1992. It employs on average 18,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0447.796.540

Incorporation

13/07/1992

Legal form

Private limited company

Contributed capital

200 000,00 €

Latest accounts

31/12/2025

Average workforce

18,6 ETP

Joint committees (3)

305
330
330206

Signals

ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	1,9 M €	+50.0%	1,2 M €	-26.3%	1,7 M €	-15.1%	2 M €	-50.9%	4 M €	+230%	1,2 M €	-3.2%	1,3 M €	+8.3%	1,2 M €	-0.9%	1,2 M €	+12.1%	1 M €	-22.3%	1,4 M €	-14.0%	1,6 M €	+3.8%	1,5 M €	+30.3%	1,2 M €	-0.8%	1,2 M €	+2.7%	1,1 M €	-3.7%	1,2 M €	+3.8%	1,1 M €	+4.8%	1,1 M €
EBITDA	563,2 k €	+591%	-114,6 k €	-150%	228,7 k €	-45.9%	422,8 k €	-83.7%	2,6 M €	+2010%	123,2 k €	-37.1%	195,8 k €	+136%	82,9 k €	+141%	34,4 k €	+147%	-73,4 k €	-134%	213,6 k €	-49.6%	424,1 k €	+16.2%	365,1 k €	+479%	63 k €	-17.2%	76,1 k €	-5.8%	80,8 k €	-60.5%	204,4 k €	+60.3%	127,6 k €	-16.6%	152,9 k €
Operating result	440,3 k €	+290%	-232,2 k €	-305%	113,1 k €	-64.1%	315,2 k €	-87.5%	2,5 M €	+3413%	71,6 k €	-54.0%	155,8 k €	+205%	51,1 k €	+1578%	-3,5 k €	+96.9%	-111,9 k €	-173%	153,1 k €	-57.1%	356,9 k €	+10.5%	323 k €	+894%	32,5 k €	-19.5%	40,3 k €	+39.0%	29 k €	-78.5%	134,7 k €	+295%	34,1 k €	+29.5%	26,3 k €
Net result	385,2 k €	+268%	-228,7 k €	-407%	74,4 k €	-76.4%	315,9 k €	-84.2%	2 M €	+3604%	54,1 k €	-58.8%	131,3 k €	+141%	54,5 k €	+1234%	4,1 k €	+104%	-102,3 k €	-198%	104,5 k €	-55.5%	234,9 k €	+9.7%	214,1 k €	+885%	21,7 k €	+121%	9,8 k €	-49.8%	19,6 k €	-74.8%	77,8 k €	+345%	17,5 k €	+64.6%	10,6 k €
Balance sheet
Equity	778,2 k €	-34.8%	1,2 M €	-59.2%	2,9 M €	+2.6%	2,8 M €	+0.6%	2,8 M €	+259%	788 k €	+7.4%	733,9 k €	+9.1%	672,6 k €	+8.8%	618,1 k €	+0.7%	614 k €	-14.3%	716,4 k €	-11.8%	811,9 k €	+40.7%	577 k €	+2.5%	562,9 k €	+4.0%	541,1 k €	+1.9%	531,3 k €	+3.8%	511,7 k €	+17.9%	433,9 k €	+4.2%	416,4 k €
Total assets	1,9 M €	-8.3%	2,1 M €	-36.5%	3,3 M €	-8.9%	3,6 M €	-4.6%	3,8 M €	+266%	1 M €	+0.4%	1 M €	+9.0%	943 k €	+9.0%	865 k €	+3.1%	838,8 k €	-23.3%	1,1 M €	-14.4%	1,3 M €	-9.0%	1,4 M €	+2.2%	1,4 M €	+13.1%	1,2 M €	-17.3%	1,5 M €	+33.6%	1,1 M €	+29.5%	847,8 k €	-2.3%	868 k €
Cash	825,2 k €	+55.6%	530,3 k €	-49.6%	1,1 M €	-25.3%	1,4 M €	-19.2%	1,7 M €	+260%	484,6 k €	-2.2%	495,2 k €	+12.8%	439 k €	+20.1%	365,6 k €	+25.0%	292,5 k €	-50.7%	592,7 k €	+51.0%	392,6 k €	-29.0%	553,3 k €	+9.7%	504,3 k €	+2.6%	491,4 k €	-34.5%	750,8 k €	+1239%	56,1 k €	-68.1%	175,9 k €	+46.4%	120,2 k €
Debts	1,1 M €	+27.1%	893,1 k €	+146%	362,4 k €	-52.2%	758,3 k €	-19.9%	946,7 k €	+288%	243,7 k €	-17.0%	293,6 k €	+8.6%	270,4 k €	+9.5%	246,8 k €	+9.9%	224,7 k €	-40.4%	376,9 k €	-18.9%	464,7 k €	-43.7%	825,2 k €	+2.1%	808,6 k €	+20.3%	671,9 k €	-28.2%	935,2 k €	+59.6%	586 k €	+53.6%	381,4 k €	-15.6%	451,6 k €
Other
Workforce	18,6 ETP	-2.1%	19,0 ETP	-23.4%	24,8 ETP	0.0%	24,8 ETP	-1.6%	25,2 ETP	+17.2%	21,5 ETP	+4.4%	20,6 ETP	0.0%	20,6 ETP	-9.3%	22,7 ETP	-12.7%	26,0 ETP	+4.0%	25,0 ETP	-2.0%	25,5 ETP	0.0%	25,5 ETP	+4.1%	24,5 ETP	-15.2%	28,9 ETP	+7.8%	26,8 ETP	+6.8%	25,1 ETP	+6.4%	23,6 ETP	-4.1%	24,6 ETP

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 22 ended

Active mandates

DE ARK

Director · 0662.986.783

Represented by Thomas Maenhout

Active

Ended mandates

DE ARK

Director · since 21 décembre 2023 · 0662.986.783

Represented by Thomas Maenhout

Ended

Thomas Maenhout

Director · since 21 décembre 2023

Ended

BIO - D

Manager · since 09 octobre 2014 · until 08 octobre 2020 · 0433.035.813

Represented by Dominique Cuigniez

Ended

BIO - D

Director · since 09 octobre 2014 · until 08 octobre 2020 · 0433.035.813

Represented by Dominique Cuigniez

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	24/03/2026	23/05/2025	12/07/2024	27/07/2023	31/08/2022	31/08/2021
General meeting	20/03/2026	05/05/2025	15/06/2024	30/06/2023	27/06/2022	08/03/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	20/03/2026	24/03/2026	Dutch	PDF
Abridged model	31/12/2024	05/05/2025	23/05/2025	Dutch	PDF
Abridged model	31/12/2023	15/06/2024	12/07/2024	Dutch	PDF
Abridged model	31/12/2022	30/06/2023	27/07/2023	Dutch	PDF
Abridged model	31/12/2021	27/06/2022	31/08/2022	Dutch	PDF
Abridged model	31/12/2020	08/03/2021	31/08/2021	Dutch	PDF
Abridged model	31/12/2019	16/08/2020	30/09/2020	Dutch	PDF
Abridged model	31/12/2018	11/03/2019	30/08/2019	Dutch	PDF
Abridged model	31/12/2017	12/03/2018	06/07/2018	Dutch	PDF
Abridged model	31/12/2016	20/03/2017	29/08/2017	Dutch	PDF
Abridged model	31/12/2015	21/03/2016	30/08/2016	Dutch	PDF
Abridged model	31/12/2014	09/03/2015	02/07/2015	Dutch	PDF
Abridged model	31/12/2013	10/10/2014	15/10/2014	Dutch	PDF
Abridged model	31/12/2012	10/10/2014	15/10/2014	Dutch	PDF
Abridged model	31/12/2011	10/10/2014	15/10/2014	Dutch	PDF
Abridged model	31/12/2010	10/10/2014	15/10/2014	Dutch	PDF
Abridged model	31/12/2009	03/10/2013	04/10/2013	Dutch	PDF
Abridged model	31/12/2008	03/10/2013	04/10/2013	Dutch	PDF
Abridged model	31/12/2007	26/09/2008	30/09/2008	Dutch	PDF
Abridged model	31/12/2006	25/05/2007	05/06/2007	Dutch	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 22 ended

Active mandates

DE ARK

Director · 0662.986.783

Represented by Thomas Maenhout

Active

Ended mandates

DE ARK

Director · since 21 décembre 2023 · 0662.986.783

Represented by Thomas Maenhout

Ended

Thomas Maenhout

Director · since 21 décembre 2023

Ended

BIO - D

Manager · since 09 octobre 2014 · until 08 octobre 2020 · 0433.035.813

Represented by Dominique Cuigniez

Ended

BIO - D

Director · since 09 octobre 2014 · until 08 octobre 2020 · 0433.035.813

Represented by Dominique Cuigniez

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Dissolution29/07/2026
RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring06/05/2026
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates02/04/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates22/12/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
PDF
Mandates05/10/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates15/01/2015
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025385,2 k €↑
2024
Annual accounts 2024-228,7 k €↓
2023
Annual accounts 202374,4 k €↓
2022
Annual accounts 2022315,9 k €↓
2021
Annual accounts 20212 M €↑
2019
Annual accounts 201954,1 k €↓
2018
Annual accounts 2018131,3 k €↑
2017
Annual accounts 201754,5 k €↑
2016
Annual accounts 20164,1 k €↑
2015
Annual accounts 2015-102,3 k €↓
2014
Annual accounts 2014104,5 k €↓
2013
Annual accounts 2013234,9 k €↑
2012
Annual accounts 2012214,1 k €↑
2011
Annual accounts 201121,7 k €↑
2010
Annual accounts 20109,8 k €↓
2009
Annual accounts 200919,6 k €↓
2008
Annual accounts 200877,8 k €↑
2007
Annual accounts 200717,5 k €↑
2006
Annual accounts 200610,6 k €
13/07/1992
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

MEDISCH LABORATORIUM

Overview

What does MEDISCH LABORATORIUM do?

Trend over 19 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline